Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmirtazapine in Chronic Primary Insomnia (RUBY)
NCT00482612Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2006
- Primary completion
- Aug 2008
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of esmirtazapine in Insomnia, sponsored by Merck & Co. Started Dec 2006; status: completed.
02
Drugs
esmirtazapine
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00482612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482612.